Want to create interactive content? It’s easy in Genially!
1.5 Regulations Summary
Biomerieux
Created on June 28, 2024
Start designing with a free template
Discover more than 1500 professional designs like these:
View
Akihabara Connectors Infographic
View
Essential Infographic
View
Practical Infographic
View
Akihabara Infographic
View
Interactive QR Code Generator
View
Witchcraft vertical Infographic
View
Halloween Horizontal Infographic
Transcript
3P ENTERPRISE
Compendial environmental monitoring
Automated method
The special feature of the 3P solution is that it's not an alternative method, but an automated one: automatic reading instead of manual reading.
SCANRDI
Alternative Sterility Method
Still only known as an alternative method even if several texts are currently under development as described below: US: The specific guideline for sterility testing for short-life sterile products is USP <1071>. A new mandatory one dedicated to cytometry approach is on going major revision: USP <74> for the detection of Contamination in Short Life Products
Full validation of a rapid sterility test must demonstrate its equivalence (or superiority) to the compendial method.
GMP ANNEX 15
GMP is MANDATORY governed by 21 of the Code of Federal Regulations explaining what to do. This Annex describes the principles of QUALIFICATION and VALIDATION which are applicable to the facilities, equipment, utilities and processes used for the manufacture of medicinal products and may also be used as supplementary optional guidance for active substances without introduction of additional requirements to EudraLex, Volume 4, Part II.
Notice: GMP can also be called cGMP for current GMP
BACT/ALERT 3D
Alternative Sterility Method except for Short Life Product in some regions
Full validation of a rapid sterility test must demonstrate its equivalence (or superiority) to the compendial method (Ph. Eur. 2.6.1 / USP <71> / JP 4.06).
Full validation of a rapid sterility test must demonstrate its equivalence (or superiority) to the compendial method. Notice that for Short-shlef life product, USP<1071> give some adapted guidelines.
3P ENTERPRISE
Automation of customer's Environmental Monitoring process
The special feature of the 3P solution is that it's not an alternative method, but an automated one. BUT If the customer changes his process as:
- Single temperature or
- Shorter incubation time,
Then the method becomes alternative.
ENDONEXT Solution
Alternative & Compendial endotoxine detection
The current compendial method for the detection of endotoxin is the LAL Method, using blood cells from Horseshoe crab compare to ENDONEXT™ Endotoxin Detection Assays which is based on recombinant Horseshoe Crab Factor C (rFC).
The rFC approach gaining acceptance in many regions being more and more compendial.
ENDONEXT solution
Compendial in EUROPE and soon in US
- EUROPE: EP 2.6.32
- US: USP <86>
ALTERNATIVE APPROACH
Identification ranges
USP<1113> "MICROBIAL CHARACTERIZATION, IDENTIFICATION, AND STRAIN TYPING"
The special feature of these ranges is that the method never involves the customer's product.
There is never any question of Method suitability testing or non-interference. To verify these methods, the parameters listed in the texts relating to alternative methods must be assessed, such as Sensitivity, Specificity, Reproducibility...
BACT/ALERT 3D
The range that is compendial according to the most widespread texts in the world but only for short shelf life products.
- EUROPE: for Cell-based preparation only - EP 2.6.27
- US:
- CHINA: ChP 9406
CoMPENDIAL APPROACH
USP <1225>
Validation of Compendial Procedures
USP <1226>
Verification of Compendial Procedures
When a method is compendial, only the method's suitability with the product is required.
BIOFIRE MYCOPLASMA
Alternative Mycoplasma detection
NAT approach is currently described in pharmacopoeia but still in an alternative status. Several texts are under development to used NAT as compendial method but still not published.
USP <77> Mycoplasma Nucleic Acid Amplification Tests and EP 2.6.7 : onGoing
ALTERNATIVE APPROACH
USP <1223>
EP 5.1.6
JP G4.6.170
The chapters of the Pharmacopoeia dedicated to validation are guidelines and explain how to do.
Same for PDA TR33
Full validation of an alternative method must demonstrate its equivalence (or superiority) to the compendial method.
